Skip to main content
. 2018 Oct 19;11(1):129–144. doi: 10.1080/19420862.2018.1530920

Figure 14.

Figure 14.

Biological activities comparison of fractionated SB5 and the reference product.

TNF binding activity per fractions for charge variants of adalimumab (left) and CDC activity per fractions for charge variants of adalimumab (right). Results from 1 batch of SB5, 1 lot of EU Humira®, and 1 lot of US Humira® are presented.